Investing at the
Convergence of Technology
and Humanity
About Us
Symbious Capital is Early-stage Venture Fund Investing in Technological Convergence.
We employ a thesis driven approach backing founders focused among the cross-sections of Ownership and Agency, Human Optimization, Longevity, and Future Infrastructure, .
The Team
Kenneth Huynh
Gartner + PwC + EMC | Multiple Exits | Former ARC Fund
Chris McLaughlin
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Research
Startup Portfolio Research 2023
nibh dignissim semper. Phasellus consequat sed augue et suscipit. In suscipit nisi id dui ornare, a fringilla metus porttitor. Sed ac ultricies massa. Sed facilisis blandit lacus. Phasellus posuere id urna ut congue. Fusce scelerisque mollis dignissim. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Pellentesque tempus dui sed nibh interdum, vel finibus eros volutpat. Nam in tempus neque. Proin dapibus ex ex, a bibendum nunc finibus non. Maecenas ornare tristique ex, eu pretium metus suscipit quis.
Portfolio Themes
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Faucibus turpis in eu mi bibendum neque
Augmenting Human Capacity
Powering Future Infrastructure
Longevity and
Health
Ownership and
Agency
Contact Us
For Start Ups
For Investors & Advisers
For Start Ups
For Investors & Advisers
